G1 Therapeutics, Inc. (NASDAQ:GTHX) Q3 2022 Earnings Conference Call November 2, 2022 8:30 AM ET Company Participants Will Roberts - VP, Communications Jack Bailey - CEO Raj Malik - CMO Andrew Perry - CCO Jen Moses - CFO Conference Call Participants Gil Blum - Needham & Company Dane Leone - RJF Ed White - H.C. Wainwright Malcolm Kuno - JPM David Nierengarten - Wedbush PacGrow Troy Langford - Cowen and Company Tony Butler - ROTH Capital Partners Operator Hello and thank you for standing by. Welcome to the G1 ...

| --- | --- | --- | --- | |--------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | Optimizing Chemotherapy, | | | | | Advancing Survival | | | | | | | | | | September 2022 | | | | | | | | | 1 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "expect," "plan," "anticipate," "estimate," "intend" and similar expressions (as well as other words or ex ...

Symbotic Inc. (SYM) Q3 2022 Earnings Conference Call August 1, 2022 5:00 PM ET Company Participants Will Roberts - Head-Corporate Communications Jack Bailey - CEO Jen Moses - CFO Andrew Perry - Chief Commercial Officer Raj Malik - Chief Medical Officer Conference Call Participants Gil Blum - Needham & Company Kaveri Pohlman - BTIG Tony Butler - ROTH Capital Edward White - H.C. Wainwright David Nierengarten - Wedbush Securities Anupam Rama - JPMorgan Troy Langford - Cowen Operator Good day, and thank you for ...

| --- | --- | --- | --- | |--------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | Optimizing Chemotherapy, | | | | | Advancing Survival | | | | | | | | | | May 4, 2022 | | | | | | | | | 1 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "expect," "plan," "anticipate," "estimate," "intend" and similar expressions (as well as other words or expre ...

G1 Therapeutics, Inc. (NASDAQ:GTHX) Q4 2021 Earnings Conference Call February 23, 2022 8:30 AM ET Company Participants | --- | |----------------------------------------------| | | | Will Roberts – Head-Corporate Communications | | Jack Bailey – Chief Executive Officer | | Andrew Perry – Chief Commercial Officer | | Raj Malik – Chief Medical Officer | | Jen Moses – Chief Financial Officer | | Conference Call Participants | | Gil Blum – Needham & Company | | Kaveri Pohlman – BTIG | | Edward White – H.C. Wainw ...

1 | --- | --- | |--------------------------|-------| | | | | | | | | | | Optimizing Chemotherapy, | | | | | | Advancing Survival | | | November 2021 | | Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "expect," "plan," "anticipate," "estimate," "intend" and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) a ...

G1 Therapeutics, Inc. (NASDAQ:GTHX) Q3 2021 Earnings Conference Call November 3, 2021 8:30 AM ET Company Participants Will Roberts – Vice President, Investor Relations & Corporate Communications Jack Bailey – Chief Executive Officer Andrew Perry – Chief Commercial Officer Raj Malik – Chief Medical Officer Jen Moses – Chief Financial Officer Conference Call Participants Kaveri Pohlman – BTIG Operator Good day, and thank you for standing by. Welcome to the G1 Therapeutics Third Quarter 2021 Financial Results ...

1 | --- | --- | --- | |--------------------------|-------|-------| | | | | | | | | | Optimizing Chemotherapy, | | | | Advancing Survival | | | | August 2021 | | | Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "expect," "plan," "anticipate," "estimate," "intend" and similar expressions (as well as other words or expressions referencing future events, conditions or circum ...

G1 Therapeutics, Inc. (NASDAQ:GTHX) Q2 2021 Earnings Conference Call August 4, 2021 4:30 PM ET Company Participants William Roberts - VP, IR & Corporate Communications John Bailey - CEO, President & Director Jennifer Moses - CFO Rajesh Malik - Chief Medical Officer and SVP of R&D Conference Call Participants Chad Messer - Needham & Company Joseph Thome - Cowen and Company Thomas Shrader - BTIG David Nierengarten - Wedbush Securities Tony Butler - Roth Castle Operator Good day. Thank you for standing by, and ...

G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2021 Earnings Conference Call May 5, 2021 4:30 PM ET Company Participants Will Roberts - Head of Investor Relations Jack Bailey - Chief Executive Officer Soma Gupta - Chief Commercial Officer Raj Malik - Chief Medical Officer Jennifer Moses - Chief Financial Officer Conference Call Participants Anthony Butler - ROTH Capital Chad Messer - Needham & Company Joe Thome - Cowen & Company Ed White - H.C. Wainwright Operator Ladies and gentlemen, thank you for standing by and ...